1. Home
  2. TOVX vs BNKK Comparison

TOVX vs BNKK Comparison

Compare TOVX & BNKK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Theriva Biologics Inc.

TOVX

Theriva Biologics Inc.

N/A

Current Price

$0.22

Market Cap

11.1M

Sector

Health Care

ML Signal

N/A

BNKK

Bonk Inc.

N/A

Current Price

$1.46

Market Cap

10.6M

ML Signal

N/A

Company Overview

Basic Information
Metric
TOVX
BNKK
Founded
2001
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Package Goods/Cosmetics
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
11.1M
10.6M
IPO Year
2012
2020

Fundamental Metrics

Financial Performance
Metric
TOVX
BNKK
Price
$0.22
$1.46
Analyst Decision
Buy
Analyst Count
2
0
Target Price
★ $2.50
N/A
AVG Volume (30 Days)
363.9K
★ 555.5K
Earning Date
08-11-2026
11-18-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 89.07
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $2,117,309.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 201.63
52 Week Low
$0.16
$0.11
52 Week High
$0.86
$7.19

Technical Indicators

Market Signals
Indicator
TOVX
BNKK
Relative Strength Index (RSI) 44.85 47.36
Support Level $0.17 $1.19
Resistance Level $0.26 $1.54
Average True Range (ATR) 0.01 0.21
MACD 0.00 -0.04
Stochastic Oscillator 27.17 4.72

Price Performance

Historical Comparison
TOVX
BNKK

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system. Product Candidates includes SYN-004 (ribaxamase) and SYN-020.

About BNKK Bonk Inc.

Bonk Inc provides over-the-counter products and consumer products in the United States. The company offers Safety Shot Beverage, an over-the-counter drink that lowers blood alcohol content. It sells its products through direct customers, distributors, retailers, and e-commerce websites. The company generates revenue through various channels, its primary sales include nostingz suncare products which are sold through e-commerce platforms, licensing revenues from Photocil and sales of the Safety Shot Beverage. The company has two reportable segments: the dietary and energy beverage business and digital assets, consisting of investing for growth in the appreciation of the asset. It derives the majority of the revenue from the dietary and energy beverage segment.

Share on Social Networks: